Spread of Hand Infection According to the Site of Entry and Its Impact on Treatment Decisions

2020 ◽  
Author(s):  
Khaled Dastagir ◽  
Malte Vehling ◽  
Sören Könneker ◽  
Alperen Sabri Bingoel ◽  
Alexander Kaltenborn ◽  
...  
Keyword(s):  
Treatment Decisions ◽  
Hand Infection ◽  
Impact On Treatment

Patients’ perception of information about HAART: impact on treatment decisions

AIDS Care ◽  
2005 ◽  
Vol 17 (3) ◽  
pp. 367-376 ◽  
Author(s):  
G. Gellaitry ◽  
V. Cooper ◽  
C. Davis ◽  
M. Fisher ◽  
H. Leake Date ◽  
...  
Keyword(s):  
Treatment Decisions ◽  
Impact On Treatment

scholarly journals Real-world bone turnover marker use: impact on treatment decisions and fracture

2020 ◽  
Author(s):  
N. E. Lane ◽  
K. Saag ◽  
T. J. O’Neill ◽  
M. Manion ◽  
R. Shah ◽  
...  
Keyword(s):  
Bone Turnover ◽  
Real World ◽  
Bone Turnover Marker ◽  
Treatment Decisions ◽  
Impact On Treatment

Prostate Cancer Upstaging by Planning MRI and its Impact on Treatment Decisions

2018 ◽  
Vol 102 (3) ◽  
pp. e88-e89
Author(s):  
G. Mok ◽  
D. Duplan ◽  
A.S. Gauthier-Pare ◽  
L. Igidbashian ◽  
V. Khahiri ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Treatment Decisions ◽  
Impact On Treatment

Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR).

2018 ◽  
Vol 36 (6_suppl) ◽  
pp. TPS154-TPS154 ◽  
Author(s):  
Todd Matthew Morgan ◽  
David Christopher Miller ◽  
Rodney Dunn ◽  
Linsell Susan ◽  
Linda Okoth ◽  
...  
Keyword(s):  
High Risk ◽  
Radical Prostatectomy ◽  
Treatment Decisions ◽  
Risk Of Recurrence ◽  
Clinical Center ◽  
Patient Reported ◽  
Impact On Treatment ◽  
The Impact

TPS154 Background: Approximately 30% of patients will have ≥pT3 disease and/or positive surgical margins at radical prostatectomy (RP), indicating a high risk of local recurrence. While current guidelines recommend consideration of adjuvant radiotherapy (aRT) in this setting, < 10% undergo aRT. The Decipher assay is a novel, tissue-based genomic classifier (GC) developed and validated in the post-RP setting as a predictor of metastasis. Current retrospective evidence suggests that patients with a high GC score may benefit from aRT, while observation may be safe for those with a lower GC score. However, there are no randomized prospective data evaluating the clinical utility of biomarkers in men with adverse features after RP. Here we see to determine the impact of GC test results on adjuvant treatment decisions for high-risk post-RP patients vs. clinical factors alone. Methods: Genomics in Michigan ImpactiNg Observation or Radiation (G-MINOR) is a 4-year (12-month enrollment, 3-year follow-up) prospective, cluster-crossover, unblinded, study of 350 subjects from twelve Urology practices in the Michigan Urological Surgery Improvement Collaborative (MUSIC). MUSIC is a physician-led quality improvement consortium nearly all academic and community urology practices within the state of Michigan. Each clinical center participating in this trial will be randomly assigned to either a Genomic Classifier (GC)-based strategy or control arm for a period of 3 months. Patients in both arms will receive a predicted risk of recurrence based on a validated clinical nomogram, the CAPRA-S score, enabling a head-to-head comparison of the Decipher assay with a freely-available validated prognostic tool. Random assignments will be generated centrally by a study statistician and provided to centers immediately before commencing enrollment in each 3-month period. Each center will have two GC and two UC enrollment periods, maintaining study-wide balance and blinding of assignments in subsequent periods. Patients will be followed for receipt of adjuvant therapy as well as oncologic (recurrence, metastasis, and death) and patient-reported quality of life. Clinical trial information: NCT02783950.

scholarly journals A second expert pathology review of cutaneous melanoma in multidisciplinary meetings: Impact on treatment decisions

2019 ◽  
Vol 30 ◽  
pp. 72-75
Author(s):  
Johanna S. Palve ◽  
Leea K. Ylitalo ◽  
Tiina H. Luukkaala ◽  
Juha M. Jernman ◽  
Niina J. Korhonen
Keyword(s):  
Cutaneous Melanoma ◽  
Treatment Decisions ◽  
Multidisciplinary Meetings ◽  
Impact On Treatment ◽  
Pathology Review

P053 The concordance of histological examination of prostate biopsies: Discrepancy in Gleason score and D’Amico prognostic risk classification and the impact on treatment decisions

2014 ◽  
Vol 13 (5) ◽  
pp. 128-129
Author(s):  
H.H.M. Al-Itejawi ◽  
J.A. Nieuwenhuijzen ◽  
L. Rozendaal ◽  
R.J.A. Van Moorselaar ◽  
A.N. Vis
Keyword(s):  
Histological Examination ◽  
Gleason Score ◽  
Treatment Decisions ◽  
Risk Classification ◽  
Prostate Biopsies ◽  
Impact On Treatment ◽  
The Impact

The clinician’s perspective on sarcoma pathology reporting: impact on treatment decisions?

Pathology ◽  
2014 ◽  
Vol 46 (2) ◽  
pp. 121-125 ◽  
Author(s):  
Jean-Yves Blay ◽  
Olfa Derbel ◽  
Isabelle Ray-Coquard
Keyword(s):  
Treatment Decisions ◽  
Impact On Treatment ◽  
Pathology Reporting

Staging early ovarian cancer: Impact on treatment decisions

2010 ◽  
Vol 46 (5) ◽  
pp. 856-858
Author(s):  
Ralph S. Freedman
Keyword(s):  
Ovarian Cancer ◽  
Treatment Decisions ◽  
Early Ovarian Cancer ◽  
Impact On Treatment
Sign in / Sign up

Export Citation Format

Share Document